期刊
NATURE REVIEWS NEUROLOGY
卷 5, 期 8, 页码 458-462出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrneurol.2009.98
关键词
-
Background. a 20-year-old woman was referred to our intensive care unit with a high frequency (every 1-2 min) of focal motor seizures. she had been diagnosed as having biopsy-proven Rasmussen encephalitis (Re) of the right hemisphere 7 years previously, since when she had been treated with numerous antiepileptic drugs, as well as with continuous immunotherapies, such as tacrolimus, corticosteroids, mycophenolate mofetil, intravenous immunoglobulin and immunoadsorption. although hemispherectomy had been avoided due to slow progression of Re, she had not been seizure-free for more than 7 weeks since diagnosis. Investigations. EEG and MRI. Diagnosis. Focal motor status epilepticus associated with right hemispheric Re, causing continuous epileptic activity and unilateral atrophy with edema in the right hemisphere. Management. Immunoadsorption was used initially to treat the seizures. Once they had ceased, we used 375 mg/m(2) intravenous rituximab-a monoclonal anti-CD20 antibody-once-weekly for 4 weeks to stabilize the condition, leading to complete depletion of cd19(+) B cells. Rituximab infusions were used again when concentrations of CD19(+) B cells rose and focal seizures re-emerged. the patient remained on antiepileptic therapy (levetiracetam, oxcarbazepine, zonisamide and phenobarbital) throughout treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据